Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5887714 | Seminars in Arthritis and Rheumatism | 2015 | 4 Pages |
Abstract
Although TCZ has not yet been included among the medications recommended for the treatment of NBD, our data suggest that it may be considered for patients with refractory NBD.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Olga MD, Nicolò MD, PhD, Giulia MD, Carlo MD,